Federal Register of Legislation - Australian Government

Primary content

PB 41 of 2011 Specifications as made
This instrument amends the National Health (Pharmaceutical Benefits - Earl Supply) Instrument 2009 - specification under subsection 84AAA(2) (No. PB 30 of 2099) that lists the medicines for which Pharmaceutical Benefits Scheme Safety Net entitlements will not apply when the next supply of the same medicine is obtained within 20 days.
Administered by: Health
Registered 26 May 2011
Tabling HistoryDate
Tabled HR30-May-2011
Tabled Senate15-Jun-2011
Date of repeal 19 Mar 2014
Repealed by Health (Spent and Redundant Instruments) Repeal Regulation 2014

 

COMMONWEALTH OF AUSTRALIA

Instrument number PB 41 of 2011

National Health Act (Pharmaceutical Benefits – Early Supply) Amendment June 2011 - Specification Under Subsection 84AAA(2)

 

Amendment determination under subsection 84AAA(2) of the National Health Act 1953

 

I, Adriana Platona, Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.

 

Dated 19 May 2011

 

 

ADRIANA PLATONA

Assistant Secretary

Pharmaceutical Evaluation Branch

Department of Health and Ageing

 

 

 

Amendment determination — Pharmaceutical Benefits - Early Supply

 

 

1          Name of Instrument

 

(1)           This Instrument is the National Health Act (Pharmaceutical Benefits – Early Supply) Amendment June 2011 - specification under subsection 84AAA(2).

 

(2)           This Instrument may also be cited as No. PB 41 of 2011.


 

2          Commencement

 

This Instrument commences on 1 June 2011.

 

 

3          Amendment of PB 30 of 2009

 

Schedule 1 amends the National Health (Pharmaceutical Benefits – Early Supply) Instrument 2009- specification under subsection 84AAA(2), PB 30 of 2009.

 


Schedule 1        Amendments

[1]                       Schedule 1, after item dealing with Risedronic acid, Tablet 35 mg

insert in the columns in the order indicated:

 

 

Tablet (enteric coated) containing risedronate sodium 35mg

Oral

4

5

 

 

[2]                       Schedule 1, after item dealing with Risedronic acid

omit:

 

Risedronate sodium and calcium carbonate

Pack containing 4 tablets risedronate sodium 35 mg and 24 tablets calcium carbonate 1.25 g (equivalent to 500 mg calcium)

Oral

1

5

 

Risedronate sodium and calcium carbonate with colecalciferol

Pack containing 4 tablets risedronate sodium 35 mg and 24 sachets containing granules of calcium carbonate 2.5 g (equivalent to 1 g calcium) with colecalciferol 22 micrograms

Oral

1

5

 

 

[3]                       Schedule 1, after item dealing with Risedronic acid and calcium, Pack containing 4 tablets risedronate sodium 35 mg and 24 tablets calcium 500 mg (as carbonate)

insert in the columns in the order indicated:

 

 

Pack containing 4 enteric coated tablets risedronate sodium 35 mg and 24 tablets calcium 500 mg (as carbonate)

Oral

1

5

 

 

[4]                       Schedule 1, after item dealing with Risedronic acid and calcium with colecalciferol, Pack containing 4 tablets risedronate sodium 35 mg and 24 sachets containing granules of calcium carbonate 2.5 g with colecalciferol 22 micrograms

insert in the columns in the order indicated:

 

 

Pack containing 4 enteric coated tablets risedronate sodium 35 mg and 24 sachets containing granules of calcium carbonate 2.5 g with colecalciferol 22 micrograms

Oral

1

5

 

 

[5]                       Schedule 1, after item dealing with Telmisartan

insert in the columns in the order indicated:

 

Telmisartan with amlodipine

Tablet 40 mg-5 mg (as besylate)

Oral

28

5

 

Tablet 40 mg-10 mg (as besylate)

Oral

28

5

 

Tablet 80 mg-5 mg (as besylate)

Oral

28

5

 

Tablet 80 mg-10 mg (as besylate)

Oral

28

5